Articles

Recent Articles

* These CDC scientific articles are listed in order of date published, from 2005 to present.

Evaluation of von Willebrand factor phenotypes and genotypes in hemophilia A patients with and without identified F8 mutations.
Journal of Thrombosis and Haemostasis 2015; 13(6):1036-42
Boylan B, Rice AS, De Staercke C, Eyster ME, Yaish HM, Knoll CM, Miller CH, The Hemophilia Inhibitor Research Study Investigators.
[Read article]

Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening.
American Journal of Hematology 2015; 90(10):871-6.
Miller CH, Rice AS, Boylan B, Payne AB, Kelly FM, Escobar MA, Gill J, Leissinger C, Soucie MJ, the Hemophilia Inhibitor Research Study Group Investigators.
[Read article]

Improving the performance of factor VIII inhibitor tests in hemophilia A.
Thrombosis Research 2015; 136(6):1047-1048.
Miller CH.
[Read article]

A public health approach to the prevention of inhibitors in hemophilia.
American Journal of Preventive Medicine 2014; 47(5):669-673
Soucie JM, Miller CH, Kelly FM, Oakley M, Brown DL, Kucab P.
[Read article]

Hepatitis B vaccination is effective by subcutaneous route in children with bleeding disorders: a Universal Data Collection database analysis.
Haemophilia 2015; 21(1)[January]:e39–e43 [epublished 7 Nov 2014, DOI: 10.1111/hae.12569].
Carpenter SL, Soucie JM, Presley RJ, Ragni MV, Wicklund BM, Silvey M, Davidson H and the Hemophilia Treatment Center Network Investigators.
[Read summary]

Impact of inhibitors on hemophilia A mortality in the United States.
Am J Hematol 2015 epublished 5Feb2015 DOI: 10.1002/ajh.23957
Walsh CE, Soucie JM, Miller CH, and the United States Hemophilia Treatment Center Network.
[Read summary]

Association of overweight and obesity with the use of self and home-based infusion therapy among haemophilic men.
Haemophilia 2014; 20(3)[May]:340-348 [epublished 22 Nov 2013, DOI: 10.1111/hae.12303].
Ullman M, Zhang QC, Brown D, Grant A, Soucie JM; on Behalf of the Hemophilia Treatment Center Network Investigators.
[Read summary]

Females with FVIII and FIX deficiency have reduced joint range of motion.
Am J Hematol 2014; 89:831–836.
Sidonio RF, Mili FD, Li T, Miller CH, Hooper WC, DeBaun MR, Soucie JM and the HTCN.
[Read summary]

Functional outcomes following ankle arthrodesis in males with hemophilia: analyses using the CDC’s Universal Data Collection surveillance project.
Haemophilia 2014; 20(5)[September]:709-715 [epublished 16 Mar 2014, DOI: 10.1111/hae.12398].
Lane H, Siddiqi AEA, Ingram-Rich R, Tobase P, Ward, RS, Universal Data Collection Joint Outcome Working Group and Hemophilia Treatment Center Network Study Investigators.
[Read summary]

Prevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection database.
Haemophilia 2014;,20(1)[January]:25–31 [epublished 25 July 2013 DOI: 10.1111/hae.12229].
Puetz J, Soucie JM, Kempton CL, Monahan PE and Hemophilia Treatment Center Network (HTCN) Investigators.
[Read summary]

Severe and moderate haemophilia A and B in US females.
Haemophilia (2014), 20, e136–e143.
Di Michele DM, Gibb C, Lefkowitz JM, NI Q, Gerber LM, Ganguly A.
[Read summary]

Similarity in Joint Function Limitation in Type 3 Von Willebrand Disease and Moderate Haemophilia A.
Haemophilia 2013;19(4)[July]:595–601 [epublished 28 Mar 2013 DOI: 10.1111/hae.12119].
Sood S, Cuker A, Wang C, Metjian A, Chiang E, Soucie JM, Konkle B. Hemophilia Treatment Center Network (HTCN) Investigators.
[Read summary]

Evidence for the Transmission of Parvovirus B19 in Patients with Bleeding Disorders Treated with Plasma-derived Factor Concentrates in the Era of Nucleic Acid Test (NAT) Screening.
Transfusion 2013; 53(5)[May] 2013: 1143–1144 [epublished 24 SEP 2012 DOI: 10.1111/j.1537-2995.2012.03907.x].
Soucie JM, De Staercke C, Monahan PE, Recht M, Chitlur MB, Gruppo R, Hooper WC, Kessler C, Kulkarni R, Manco-Johnson MJ, Powell J, Pyle M, Riske B, Sabio H, Trimble S & the U.S. Hemophilia Treatment Center Network.
[Read summary]

Prevalence of Clinical Hip Abnormalities in Hemophilia A and B: An Analysis of the UDC Database.
Haemophilia 2013;19(3)[May]:426-431.
Kelly D, Zhang QC, Soucie JM, Manco-Johnson M, DiMichele D for the Joint Outcome Subcommittee of the Coordinating Committee for the Universal Data Collection Database and the Hemophilia Treatment Center Network Investigators.
[Read summary]

The Effect of Secondary Prophylaxis versus Episodic Treatment on the Range of Motion of Target Joints in Patients with Hemophilia.
British Journal of Haematology 2013;161(3)[May]:424-433.
Gupta S, Siddiqi A , Soucie JM, Manco-Johnson MJ, Kulkarni R, Lane H, Ingram-Rich R, Gill JC  of the Joint Outcomes Committee of Universal Data Collection and the Hemophilia Treatment Centers Network.
[Read summary]

Increased prevalence of inhibitors in Hispanic patients with severe haemophilia A enrolled in the Universal Data Collection database.
Haemophilia 2012;18(3)[May]:e260-e265.
Carpenter SL, Soucie JM, Sterner S, Presley R, Hemophilia Treatment Center Network (HTCN) Investigators.
[Read summary]

Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States.
British Journal of Haematology 2011;152(2):211-216.
Witmer C, Presley R, Kulkarni R, Soucie JM, Manno CS, Raffini L.
[Read summary]

Insurance, Home Therapy, and Prophylaxis in U.S. Youth with Severe Hemophilia.
AJPM 2011; 41:S338-S345.
Baker JR, Riske B, Voutsis M, Cutter S, Presley R.
[Read summary]

Physical Functioning in Boys with Hemophilia in the U.S.
AJPM 2011; 43:S360-S368.
Monahan PE, Baker JR, Riske B, Soucie JM
[Read summary]

Surveillance of female patients with inherited bleeding disorders in United States haemophilia treatment centres.
Haemophilia 2011;17 Suppl 1:6-13.
Byams VR, Kouides PA, Kulkarni R, Baker JR, Brown DL, Gill JC, Grant AM, James AH, Konkle BA, Maahs J, Dumas MM, McAlister S, Nance D, Nugent D, Philipp CS, Soucie JM, Stang E; Haemophilia Treatment Centres Network Investigators.
[Read summary]

The longitudinal effect of body adiposity on joint mobility in young males with hemophilia A.
Haemophilia 2011;17(2):196-203.
Soucie JM, Wang C, Siddiqi A, Kulkarni R, Recht M, Konkle BA, Hemophilia Treatment Center Network.
[Read summary]

Bleeding disorders in neonates.
Haemophilia 2010;16(S5):168–174.
Kenet G, Chan AKC, Soucie JM, Kulkarni R.
[Read summary]

High school completion rates among men with hemophilia.
American Journal of Preventative Medicine 2010;38(4 Suppl):S489-S494.
Drake JH, Soucie JM, Cutter SC, Forsberg AD, Baker JR, Riske B.
[Read summary]

Bleeding Symptoms and Laboratory Correlation in Patients with Severe von Willebrand Disease
Haemophilia; July 2009; Volume 15, Number 4, pp. 918-925(8)
Metjian AD, et al.
[Read summary]

Sites of Initial Bleeding Episodes, Mode of Delivery and Age of Diagnosis in Babies with Haemophilia Diagnosed Before the Age of 2 Years
Haemophilia; November 2009; Volume 15, Number 6, pp. 1281-1290(10)
Kulkarni R, et al.
[Read summary]

Septic Arthritis in Males with Haemophilia
Haemophilia; 2008; 14:494-503
Ashrani AA, Key NS, Soucie JM, Duffy N, Forsyth A, Geraghty S.
[Read summary]

Incidence of Inhibitors in a Cohort of 838 Males with Hemophilia A Previously Treated with Factor VIII Concentrates
Journal of Thrombosis and Haemostasis; 2006; 4(12):2576-2581
Kempton CL, Soucie JM, Abshire TC.
[Read summary]

Parvovirus B19 Transmission by High-Purity Factor VIII Concentrate
Transfusion; 2005; 45:1003-1010
Wu C, et al.
[Read summary]

All Articles

Search a database of articles that have been published by CDC authors within the National Center on Birth Defects and Developmental Disabilities from 1990 to present.